M&A Deal Summary |
|
|---|---|
| Date | 2013-12-04 |
| Target | Agila Specialties Pvt. |
| Sector | Medical Products |
| Buyer(s) | Viatris |
| Sellers(s) | Strides Pharma Science |
| Deal Type | Divestiture |
| Deal Value | 1.8B USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1961 |
| Sector | Life Science |
| Employees | 32,000 |
| Revenue | 14.7B USD (2024) |
Viatris is a generic and specialty pharmaceutical company. Viatris offers the industry's broadest and highest quality product portfolios, a robust product pipeline, and a global commercial footprint through operations in more than 90 countries. Viatris was founded in 1961 and is based in Canonsburg, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 14 |
| Sector: Medical Products M&A | 2 of 3 |
| Type: Divestiture M&A Deals | 2 of 6 |
| Country: India M&A | 2 of 3 |
| Year: 2013 M&A | 1 of 1 |
| Size (of disclosed) | 4 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-09-07 |
Bioniche Pharma Holdings
Lake Forest, Illinois, United States Bioniche Pharma Holdings Ltd. is a developer and manufacturer of injectable pharmaceutical products serving a variety of niche markets, including analgesics/anesthetics, orthopedics, oncology, and urology. |
Buy | $550M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-02-02 |
Famy Care
Mumbai, India Famy Care Ltd is a family owned pharmaceutical manufacturer based in India. The company specializes in the women’s healthcare market, specifically contraceptive formulations and devices. |
Buy | $750M |
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Life Science |
| Employees | 3,301 |
| Revenue | 43.9B INR (2025) |
Strides Pharma Science is a pharmaceutical company. Strides operates in pharma generics, branded generics, and biopharma. Strides Pharma Science was founded in 1990 and is based in Bangalore, Karnataka.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| Country: India M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-01-24 |
Ascent Pharmahealth
Melbourne, Australia Ascent Pharmahealth Ltd, markets in Australia, Singapore, Malaysia, Hong Kong, Vietnam, Thailand and other Asian countries with a range of generic pharmaceuticals, consumer skincare and over the-counter (OTC) medicines. Ascent has a regional manufacturing facility located in Singapore which manufactures prescription and OTC products in varied dosage forms for the Southeast Asia market. |
Sell | AU$375M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-11-25 |
PediaCare
Staten Island, New York, United States PediaCare is a provider of products for children, primarily within cough cold and analgesics segments. |
Buy | $5M |
